Market research
MDR.AU MedAdvisor Limited
AU AUD Healthcare
Latest close
As of 28 Feb 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 14M
- P/E ratio
- Not available
- Analyst target
- 0.15
- Dividend yield
- Not available
- Beta
- 1.03
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- AU000000MDR6
- Market cap
- 14M
- P/E ratio
- Not available
- Analyst target
- 0.15
- Dividend yield
- Not available
- Beta
- 1.03
About
About MedAdvisor Limited
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anme to Adheris Health Limited in November 2025. The company was incorporated in 2010 and is based in Woburn, Massachusetts.
Research context
MedAdvisor Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the MDR.AU discussion.
5 years, 6 months ago
MedAdvisor Limited is currently in a long term downtrend where the price is trading 12.4% below its 200 day moving average.
From a valuation standpoint, the stock is 98.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
MedAdvisor Limited's total revenue rose by 189.4% to $13M since the same quarter in the previous year.
Its net income has dropped by 47.8% to $-8M since the same quarter in the previous year.
Finally, its free cash flow grew by 54.9% to $-1M since the same quarter in the previous year.
Based on the above factors, MedAdvisor Limited gets an overall score of 3/5.